用X射线诱导的药物释放用于癌症治疗
Hui Liu1, Jun Zhao1, Yufei Xue1
1Frontiers Science Center for Flexible Electronics, Xi'an Institute of Flexible Electronics (IFE), Xi'an Institute of Biomedical Materials & Engineering (IBME) and Ningbo Institute of Northwestern Polytechnical University, Northwestern Polytechnical University, Xi'an, 710072, China.
Angewandte Chemie (International ed. in English)
|June 6, 2023
概括
X射线为先进的药物递送系统 (DDS) 提供了一种新的刺激,通过克服光透限制,使精确的,深层组织癌症治疗成为可能. 这项技术增强了向治疗,并最大限度地降低了全身毒性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 药物输送系统 (DDS) 旨在提供有针对性的治疗,最大限度地降低全身毒性.
- 目前的光触发式DDS面临的局限性是由于紫外线和可见光在生物组织中的透率较低.
- 对于传统的光激活DDS来说,深层组织瘤治疗仍然是一个挑战.
研究的目的:
- 探索最近在X射线触发的DDS中取得的进展,以控制药物释放.
- 调查X射线作为激发深层组织癌症治疗的潜力.
- 阐明从DDS中X射线介导药物释放的机制.
主要方法:
- 关于对X射线敏感的DDS的最新文献的综述.
- 对生物应用的X射线特性进行分析 (透,可控性).
- 讨论由X射线触发的药物释放机制.
主要成果:
- 与紫外线/可见光相比,X射线显示组织透率更高.
- X射线为药物释放提供了精确的时空和剂量控制.
- 通过X射线触发的DDS显示出克服深层组织癌症治疗局限性的前景.
结论:
- 在深层组织癌症治疗中,X射线代表了DDS的可行和先进的刺激.
- 精确的X射线可控性增强了向药物输送和治疗疗效.
- 对对X射线敏感的DDS进行进一步的研究可以为有效的癌症治疗铺平新的道路.
相关概念视频
X-ray Imaging
5.6K
German physicist Wilhelm Röntgen (1845–1923) was experimenting with electrical current when he discovered that a mysterious and invisible "ray" would pass through his flesh but leave an outline of his bones on a screen coated with a metal compound. In 1895, Röntgen made the first durable record of the internal parts of a living human: an "X-ray" image (as it came to be called) of his wife’s hand. Scientists worldwide quickly began their own experiments with...
5.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


